Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Lamivudine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lamivudine 100mg tablets
0503010Q0AAADAD
|
Lamivudine | Lamivudine | Infections | 809 |
|
Zeffix 100mg tablets
0503010Q0BCABAD
|
Zeffix | Lamivudine | Infections | 26 |
|
Lamivudine 50mg/5ml oral solution
0503010Q0AAABAB
|
Lamivudine | Lamivudine | Infections | 23 |
|
Lamivudine 150mg tablets
0503010Q0AAAAAA
|
Lamivudine | Lamivudine | Infections | 3 |
|
Lamivudine 300mg tablets
0503010Q0AAAEAE
|
Lamivudine | Lamivudine | Infections | 1 |
|
Epivir 150mg tablets
0503010Q0BBAAAA
|
Epivir | Lamivudine | Infections | No data available |
|
Epivir 300mg tablets
0503010Q0BBACAE
|
Epivir | Lamivudine | Infections | No data available |
|
Epivir 50mg/5ml oral solution
0503010Q0BBABAB
|
Epivir | Lamivudine | Infections | No data available |
|
Lamivudine 25mg/5ml oral solution
0503010Q0AAACAC
|
Lamivudine | Lamivudine | Infections | No data available |
|
Zeffix 5mg/ml oral solution
0503010Q0BCAAAC
|
Zeffix | Lamivudine | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.